Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in IMMUNITYBIO INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 461,176 shares of IBRX (IMMUNITYBIO INC), worth $913,128 as of 2025-Q4. The position was increased (++9.1% shares). IBRX represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$913,128
Current Shares
461,176
Total Value Change
-$9.1M
Total Shares Change
-1.1M
Other major holders of IBRX: BNP PARIBAS FINANCIAL MARKETS, STATE STREET CORP, BlackRock Finance, Inc., VANGUARD GROUP INC
Increased |
| 461,176 |
+9.1% |
| $913,128 |
| 0.0% |
| $1.98 |
27 |
| 2025-Q3 | Decreased | 422,831 | -45.9% | $1M | 0.0% | $2.57 | 0 |
| 2025-Q2 | Increased | 781,800 | +80.8% | $2.1M | 0.0% | $2.70 | 40 |
| 2025-Q1 | Increased | 432,341 | +65.2% | $1.3M | 0.0% | $3.14 | 37 |
| 2024-Q4 | Decreased | 261,734 | -83.1% | $670,041 | 0.0% | $2.68 | 0 |
| 2024-Q3 | Decreased | 1.5M | -2.1% | $5.7M | 0.0% | $3.93 | 0 |
| 2024-Q2 | Increased | 1.6M | +762.5% | $10M | 0.0% | $6.32 | 45 |